Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial

Bronchiolitis obliterans syndrome (BOS) remains the major problem which precludes long-term survival after lung transplantation. Previously, an open label pilot study from our group demonstrated a possible beneficial effect of montelukast in progressive BOS patients with low airway neutrophilia (<...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:PLoS One
Autori principali: Ruttens, David, Verleden, Stijn E., Demeyer, Heleen, Van Raemdonck, Dirk E., Yserbyt, Jonas, Dupont, Lieven J., Vanaudenaerde, Bart M., Vos, Robin, Verleden, Geert M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2018
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5889063/
https://ncbi.nlm.nih.gov/pubmed/29624575
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0193564
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi